Resmed Inc. diskutieren
Resmed Inc.
WKN: 895878 / Symbol: RMD / Name: ResMed / Aktie / Ausrüstung & Versorgung / Large Cap /
202,10 €
0,64 %
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $238.00 to $251.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its "underperform" rating re-affirmed by analysts at Wolfe Research. They now have a $180.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Bank of America Co. from $240.00 to $270.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Robert W. Baird from $280.00 to $283.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $251.00 to $266.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $286.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at KeyCorp from $280.00 to $269.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at UBS Group AG from $290.00 to $285.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
Neueste Beiträge
StockNews_com in Crane Holdings Co. diskutieren